Fujian Cosunter Pharmaceutical Co.Ltd(300436)
Independent directors’ opinions on the 12th meeting of the 4th board of directors
Prior approval opinions on relevant matters
In accordance with the guiding opinions on the establishment of independent director system in listed companies, the Listing Rules of GEM stocks of Shenzhen Stock Exchange, the self regulatory guidelines for listed companies of Shenzhen Stock Exchange No. 2 – standardized operation of GEM listed companies, the articles of association, the company’s independent director working system and relevant laws and regulations, As an independent director of Fujian Cosunter Pharmaceutical Co.Ltd(300436) (hereinafter referred to as “the company”), we reviewed the proposal of the 12th meeting of the 4th board of directors in advance, and issued the following prior approval opinions on the basis of understanding relevant information:
1、 Prior approval opinions on signing technical service contract and related party transactions
This related party transaction of the company is conducive to making full use of the company’s resources and improving the use efficiency of the company’s assets. The transaction price refers to the market fair price. After negotiation and determination by both parties, there is no situation that damages the interests of the company and other shareholders, especially minority shareholders. We unanimously agreed to submit the proposal on signing technical service contract and related party transactions to the 12th meeting of the Fourth Board of directors of the company for deliberation. Mr. Li Guoqing and Ms. Li Guodong should withdraw from the board of directors when considering the above connected transactions. (no text below)
(there is no text on this page, which is the signature page of Fujian Cosunter Pharmaceutical Co.Ltd(300436) independent director’s prior approval opinions on matters related to the 12th meeting of the 4th board of directors) signature of independent director:
Ren Hong, Chen Mingyu, Qiang Xinrong
Fujian Cosunter Pharmaceutical Co.Ltd(300436) board of directors date 2022
